GlassScriptPhysician profile
Christopher M Larson
NPI 1396763314
$324,203.62
in general payments reported to CMS, 2019-2025
4 companies · $79K in 2025
The $79K reported for 2025 was more than what 96% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $47K · 2020: $44K · 2021: $33K · 2022: $9,835 · 2023: $50K · 2024: $62K · 2025: $79K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $74K · Consulting Fee: $64K · Royalty Or License: $44K · Travel and Lodging: $5,625 · Food and Beverage: $3,403.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $73,995.00 |
| Consulting Fee | $63,840.00 |
| Royalty Or License | $43,863.95 |
| Travel and Lodging | $5,624.78 |
| Food and Beverage | $3,402.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $304,662.51 | 2019-2025 | Cap-Fix, Bone Anchors With Arthroscopic Delivery System, Spatial Frame |
| Responsive Arthroscopy INC | $14,209.63 | 2021-2025 | Responsive Arthroscopy Devices, Responsive Arthroscopy Devices |
| Synthes Gmbh | $5,299.22 | 2019 | |
| Orthofix Medical, INC. | $32.26 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$436,025.15 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Larson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.